Japanese Companies Sue Government Over New OTC Online Purchase Regulation
This article was originally published in PharmAsia News
Two major online marketing companies in Japan, Kenko.com and Wellnet filed May 25 a lawsuit against the government over online purchase regulations for over-the-counter drugs. A ministerial ordinance from the Ministry of Health, Labor and Welfare requires face-to-face transactions for OTC drugs categorized as class 1 and 2. A pharmacist explanation is required for class 1 drugs, and an explanation from a pharmacist or a registered seller is required for class 2 drugs. Japanese online marketers consider the regulation an actual ban on the online purchase of the drugs. The two companies claim that the government's decision to ban Internet sales went beyond its jurisdiction. (Click here for more - Japanese language
You may also be interested in...
Russia is promising the best of both worlds – a low price with a near-perfect efficacy. While the basic science is plausible, its best-in-class claims are bound to generate skepticism.
The Belgian biotech has divested its drug discovery services unit in Croatia which was making a nice profit but was not a priority as Galapagos concentrates on setting up its commercial operations in Europe.
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.